Back
Hepion Pharmaceuticals, Inc. 10K Form
Sell
29
HEPA
Hepion Pharmaceuticals, Inc.
Last Price:
$0.07
Seasonality Move:
-6.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HEPA News And Ratings
See the #1 stock for the next 7 days that we like better than HEPA
HEPA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-446K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.14 |
| Price / Book: | 0.44 |
Profitability
| EPS (TTM): | -13.40470 |
|---|---|
| Net Income (TTM): | $-9.2M |
| Gross Margin: | $-30.8K |
| Return on Equity: | -524.07% |
| Return on Assets: | -230.44% |
Hepion Pharmaceuticals, Inc. Earnings Forecast
Key Hepion Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 5 years.
Hepion Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | HEPA |
| CUSIP: | 426897 |
| Website: | hepionpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 10.77 |
| Quick Ratio: | 6.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HEPA Technical Analysis vs Fundamental Analysis
Sell
29
Hepion Pharmaceuticals, Inc. (HEPA)
is a Sell
Is Hepion Pharmaceuticals, Inc. a Buy or a Sell?
-
Hepion Pharmaceuticals, Inc. stock is rated a SellThe current Hepion Pharmaceuticals, Inc. [HEPA] share price is $0.07. The Score for HEPA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.